US FDA

Warning Letter Woes: Dr Reddy’s Expects FDA Inspection Of AP Plant By Year End - Sakshi Post

Warning Letter Woes: Dr Reddy’s Expects FDA Inspection Of AP Plant By Year End

Jul 31, 2019
Dr Reddy’s Laboratories was expecting an inspection of its Active Pharmaceuticals Ingredients (API) plant at Srikakulam in Andhra Pradesh
The company has received final approval from the United States Food & Drug Administration (USFDA) to manufacture and market Linezolid injection, 600 mg/300 mL (2 mg/mL),  - Sakshi Post

Aurobindo Pharma gets USFDA nod for anti-infective injection

Aug 08, 2016
This takes total ANDA approvals to 275
Back to Top